Anti-glycemic Agents

Random Miscellaneous Quiz

Can you name the Anti-glycemic Agents?

Quiz not verified by Sporcle

How to Play
Challenge
Share
Tweet
Embed
HintAnswer
SE: No hypoglycemia
Glusine - Apidra (Avemtis) class
Onset: 1-2 hours
MOA: Inhibit enzymatic degradation of incretin hormones. Unlike most PO meds for DM, does not promote wt gain, there may even be slight wt loss.
Use: Human insulin is made by recombinant technology
Contraindications: Intestinal dz, cirrhosis, renal dz (creatinine > 2)
Miglitol class
Humalog Mix 50/50 class
Repalinide class
Nololin 70/30
SE: GI effects, increased transaminases (monitor). No hypoglycemia
Novolin R class
NPH Iletin III (Lilly) class
Nolvin N PenFill
Metformin and pioglitazone combo
Rosiglitazone and metformin combo
Acarbose class
MOA: Bind to SU receptor on surface of beta cells, closing K+ATP channels -> to depolarization of cell membrane, allowing Ca++ to enter cell -> in insulin secretion.
MOA: Lowers postprandial glucose rise by delaying CHO absorption. Decreases glucose absorption secondary to decreased digestion of carbohydrates.
Onset 1-4 hours
Humulin 70/30
Sitagliptin (Januvia) class
Peak 6-8 hours
Use: First-line for most DM II, esp. obese.
Novolog Mix 70/30 PenFill class
Novolin N class
Apidra class
MOA: Binds to PPAR-gamma, a nuclear receptor regulating differentiation of cells (adipocytes, vascular tissue). Decreased plasma fatty acid levels, decreased central adiposity, res
Onset 15-30 minutes
Lispro - Humalog (Lilly) class
Use: DM II. Most effective in lean patients.
Humulin N (NPH) (Lilly) class
Detemir - Levemir class
HintAnswer
Contraindications: Class III/IV CHF
Humalog Mix 75/25 class
Pioglitazone (Actos) class
Pioglitazone and glimepiride combo
Use: Onset and duration are rough within the range listed from person to person
MOA: GLP-1 agonist. Has all the properties of human GLP-1. 10 lb or greater wt loss in 1 yr
Duration 3 - 4 hours (4-5 hours)
SE: GI effects, occasional low B12, rare lactic acidosis, ovulation in PCO
MOA: Effective in long-duration DM, weight loss, no hypoglycemia, lowers insuling, TG, LDL
Peak: None
MOA: Lowers threshold for insulin release. Effective early; secondary failure common.
SE: Similar to sulfonureas but with less risk of prolonged hypoglycemia.
Peak 2 - 5 hours
Humulin L (Lente) (Lilly) class
Peak: 1 hour
Novolin R (Novo Nordisk) class
Rosiglitazone (Avandia) class
Metformin class
Humulin R (Lilly) class
Humalog 50/50 class
Sitagliptin and metformin combo
Nololin N (NPH) (Lilly) class
Glyburide (Micronase, Diabeta) class
Duration: 18-20 hours
P-kinetics: Eliminated by renal filtration
Duration ~14 hours
Duration 5-7 hours (6 - 8 hours)
Humulin Ultralente class
Nolovin R PenFill
Novolin R PenFill
P-kinetics: Injected SQ BID
SE: Increased plasma volume, edema, CHF, ovulation in PCO, mild anemia, rare liver toxicity, risk of fx in women. No hypoglycemia
Humalog class
HintAnswer
Contraindications: Renal dz, liver dz, CHF, dehydration, shock, acidosis, alcoholism
Duration: 20-24 hours
SE: Nausea, other GI effects, rare reports of pancreatitis
Metformin and glipizide combo
Onset 30 minutes - 1 hour
Glargine - Lantus class
Novolog Mix 70/30 class
MOA: Similar to sulfonureas.
Metformin and glyburide combo
Avapro - Novalog (Novo Nordisk) class
Novolin 70/30 PenFill
Exenatide class
Use: Controls blood sugar surges at mealtime
Glimepiride (Amaryl) class
Humulin Br class
Novolin 70/30 class
Duration 18-24 hours (12-16 hours)
P-kinetics: 100 mg once daily
Novolog Mix 70/30 class
Use: Combines rapid-acting and intermediate-acting insulin. Controls blood sugar at mealtime and all day and night
Humalog 75/25 Mix class
MOA: Increases hepatic insulin sensitivity. Works through AMP dependent kinase, a mastor allosteric regulator of metabolism, that senses lack of energy substrates in cells.
Humulin 50/50
Novolog class
Regular Ileting II (Lilly) class
Glipizide (Glucotrol; Glucotrol XL) class
Humulin N class
SE: Hypoglycemia, weight gain, GI effects.
MOA: Decreases insulin resistance, increase muscle and adipose tissue glucose uptake, decreased hepatic glucose output.
Rosiglitazone and glimepiride combo
MOA: Decreases hepatic glucose production, decreases peripheral insulin resistance, increases glucose uptake, decrease gluconeogenesis, decreases fatty liver,
Use: Controls blood sugar between meals and during sleep
P-kinetics: Rapid absorption, short duration.

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.